Claims
- 1. A pK-matched buffer comprising a weak acid and a weak base which have pKa values at 25° C. within about 0.3 units of one another.
- 2. A pK-matched buffer of claim 1, wherein the weak acid is CAPSO and the weak base is ethanolamine.
- 3. A pK-matched buffer of claim 1, wherein the weak acid is ACES and the weak base is BIS-TRIS.
- 4. A pK-matched buffer of claim 1, wherein the weak acid is CAPSO and the weak base is 2-amino-2-methyl-1-propanol.
- 5. A pK-matched buffer of claim 1, wherein the weak acid is HEPES and the weak base is triethanolamine.
- 6. In an electrophoresis method, the improvement which comprises running the electrophoresis in a pK-matched buffer comprising a weak acid and a weak base which have pKa values at 25° C. within about 0.3 units of one another.
- 7. The method of claim 6, wherein the pK-matched buffer is selected from a buffer comprising CAPSO as the weak acid and ethanolamine as the weak base; a buffer comprising ACES as the weak acid and BIS-TRIS as the weak base; a buffer comprising CAPSO as the weak acid and 2-amino-2-methyl-1-propanol as the weak base; and a buffer comprising HEPES as the weak acid and triethanolamine as the weak base.
- 8. The method of claim 6, wherein the method is a gel electrophoresis method for separating nucleic acids or polypeptides.
- 9. The method of claim 7, wherein the method is a gel electrophoresis method for separating nucleic acids or polypeptides.
- 10. The method of claim 7, wherein the pk-matched buffer is a buffer comprising CAPSO as the weak acid and ethanolamine as the weak base.
- 11. The method of claim 7, wherein the pK-matched buffer is a buffer comprising ACES as the weak acid and BIS-TRIS as the weak base.
- 12. The method of claim 7, wherein the pK-matched buffer is a buffer comprising CAPSO as the weak acid and 2-amino-2-methyl-1-propanol as the weak base.
- 13. The method of claim 7, wherein the pK-matched buffer is a buffer comprising HEPES as the weak acid and triethanolamine as the weak base.
Parent Case Info
[0001] This application claims the benefit of U.S. application Ser. No. 09/536,392 filed Mar. 28, 2000, which claims the benefit of U.S. Provisional Application Serial No. 60/127,087, filed Mar. 31, 1999.
GOVERNMENT RIGHTS
[0002] This invention was made with partial funding under Grant RO1-HL 39762 from the National Institutes of Health of the United States. The United States government has certain rights in the invention.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60127087 |
Mar 1999 |
US |
Divisions (1)
|
Number |
Date |
Country |
Parent |
09536392 |
Mar 2000 |
US |
Child |
10441099 |
May 2003 |
US |